These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Edaravone: a new hope for deadly amyotrophic lateral sclerosis. Bhandari R; Kuhad A; Kuhad A Drugs Today (Barc); 2018 Jun; 54(6):349-360. PubMed ID: 29998226 [TBL] [Abstract][Full Text] [Related]
7. Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009-2011 and survival characteristics through 2015. Punjani R; Wagner L; Horton K; Kaye W Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):123-130. PubMed ID: 31795746 [TBL] [Abstract][Full Text] [Related]
8. Football increases the risk for Lou Gehrig's disease, amyotrophic lateral sclerosis. Abel EL Percept Mot Skills; 2007 Jun; 104(3 Pt 2):1251-4. PubMed ID: 17879657 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016. Mehta P; Raymond J; Punjani R; Larson T; Bove F; Kaye W; Nelson LM; Topol B; Han M; Muravov O; Genson C; Davis B; Hicks T; Horton K Amyotroph Lateral Scler Frontotemporal Degener; 2022 May; 23(3-4):220-225. PubMed ID: 34423697 [No Abstract] [Full Text] [Related]
11. A spatial analysis of amyotrophic lateral sclerosis (ALS) cases in the United States and their proximity to multidisciplinary ALS clinics, 2013. Horton DK; Graham S; Punjani R; Wilt G; Kaye W; Maginnis K; Webb L; Richman J; Bedlack R; Tessaro E; Mehta P Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):126-133. PubMed ID: 29262737 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010-2015. Raymond J; Oskarsson B; Mehta P; Horton K Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):413-420. PubMed ID: 31131638 [No Abstract] [Full Text] [Related]
13. Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care System. Vu M; Tortorice K; Zacher J; Dong D; Hur K; Zhang R; Good CB; Glassman PA; Cunningham FE JAMA Netw Open; 2020 Oct; 3(10):e2014645. PubMed ID: 33017028 [TBL] [Abstract][Full Text] [Related]
15. Amyotrophic Lateral Sclerosis Mortality in the United States, 2011-2014. Larson TC; Kaye W; Mehta P; Horton DK Neuroepidemiology; 2018; 51(1-2):96-103. PubMed ID: 29990963 [TBL] [Abstract][Full Text] [Related]
16. The epidemiology of amyotrophic lateral sclerosis. Talbott EO; Malek AM; Lacomis D Handb Clin Neurol; 2016; 138():225-38. PubMed ID: 27637961 [TBL] [Abstract][Full Text] [Related]
17. Incidence of amyotrophic lateral sclerosis in the United States, 2014-2016. Mehta P; Raymond J; Punjani R; Larson T; Han M; Bove F; Horton DK Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):378-382. PubMed ID: 35023792 [No Abstract] [Full Text] [Related]
18. Logistics and safety of edaravone treatment for amyotrophic lateral sclerosis: experience in Argentina. Quarracino C; Bendersky M; Rey R; RodrÃguez GE Acta Neurol Belg; 2021 Dec; 121(6):1519-1523. PubMed ID: 32436077 [TBL] [Abstract][Full Text] [Related]
19. Novel Selenium-based compounds with therapeutic potential for SOD1-linked amyotrophic lateral sclerosis. Amporndanai K; Rogers M; Watanabe S; Yamanaka K; O'Neill PM; Hasnain SS EBioMedicine; 2020 Sep; 59():102980. PubMed ID: 32862101 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017. Mehta P; Raymond J; Punjani R; Han M; Larson T; Kaye W; Nelson LM; Topol B; Muravov O; Genson C; Horton DK Amyotroph Lateral Scler Frontotemporal Degener; 2023 Feb; 24(1-2):108-116. PubMed ID: 35422180 [No Abstract] [Full Text] [Related] [Next] [New Search]